For the first quarter 2019: ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported its financial results for the three months ended March 31, 2019 and reaffirmed its 2019 financial guidance.
Though ANI Pharmaceuticals’s net revenue grew $5 million in 2019, the company logged a nearly $24 million increase in spending. According to ANI’s annual report released Thursday, the company logged ...
For the full year ended December 31, 2018: For the fourth quarter 2018: Guidance for 2019: ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported its financial results for the three and ...
BAUDETTE, Minn., June 12, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will present on June 18, 2019 at Raymond James' Life Sciences and MedTech Conference in New York City. Arthur ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results